Today's Big Losers: AGEN, CKSW, TCB, KCI

Market News Video
October 21, 2009 AT 2:08 PM
Antigenics (AGEN) had disappointing news for investors on Wednesday. The European Medicines Agency informed the company that it should anticipate a negative opinion from the Committee for Medicinal Products for Human Use, regarding the company's marketing authorization application for its Oncophage treatment for kidney cancer.